11511562

Source:http://linkedlifedata.com/resource/pubmed/id/11511562

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0011854, umls-concept:C0013072, umls-concept:C0066827, umls-concept:C0243192, umls-concept:C0426576, umls-concept:C0757055, umls-concept:C1280500, umls-concept:C1282910, umls-concept:C1696465, umls-concept:C2587213
pubmed:issue	3
pubmed:dateCreated	2001-8-20
pubmed:abstractText	Erythromycin, a motilin agonist, is a potent prokinetic. ABT-229 is a specific motilin agonist that dose dependently accelerates gastric emptying. Dyspepsia and gastroparesis are common problems in type 1 diabetes mellitus. We aimed to evaluate the efficacy of ABT-229 in symptomatic diabetic patients with and without delayed gastric emptying.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-10081621, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-10083872, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-10097936, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-10235199, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-10333955, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-10339636, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-10365900, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-10381885, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-10404803, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-10473966, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-10811324, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-10819233, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-11121915, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-11511547, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-12235094, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-1896807, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-3655274, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-3799578, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-3965339, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-6402969, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-6811067, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-765178, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-8253365, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-8500721, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-8528642, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-8565773, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-8817107, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-8944695, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-9051396, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-9097998, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-9146779, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-9203450, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-9218089, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-9283990, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-9548614, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-9649020, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-9663833, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-9690375, http://linkedlifedata.com/resource/pubmed/commentcorrection/11511562-9834261
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985108R
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/ABT 229, http://linkedlifedata.com/resource/pubmed/chemical/Erythromycin, http://linkedlifedata.com/resource/pubmed/chemical/Gastrointestinal Agents, http://linkedlifedata.com/resource/pubmed/chemical/Motilin
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	0017-5749
pubmed:author	pubmed-author:GeenenD JDJ, pubmed-author:HoganR BRB, pubmed-author:MaceR DRD, pubmed-author:McCallumR WRW, pubmed-author:RifeEE, pubmed-author:TalleyN JNJ, pubmed-author:VerlindenMM
pubmed:issnType	Print
pubmed:volume	49
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	395-401
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:11511562-Adolescent, pubmed-meshheading:11511562-Adult, pubmed-meshheading:11511562-Aged, pubmed-meshheading:11511562-Analysis of Variance, pubmed-meshheading:11511562-Breath Tests, pubmed-meshheading:11511562-Diabetes Mellitus, Type 1, pubmed-meshheading:11511562-Dose-Response Relationship, Drug, pubmed-meshheading:11511562-Double-Blind Method, pubmed-meshheading:11511562-Dyspepsia, pubmed-meshheading:11511562-Erythromycin, pubmed-meshheading:11511562-Female, pubmed-meshheading:11511562-Gastric Emptying, pubmed-meshheading:11511562-Gastrointestinal Agents, pubmed-meshheading:11511562-Gastroparesis, pubmed-meshheading:11511562-Humans, pubmed-meshheading:11511562-Male, pubmed-meshheading:11511562-Middle Aged, pubmed-meshheading:11511562-Motilin, pubmed-meshheading:11511562-Regression Analysis, pubmed-meshheading:11511562-Treatment Outcome
pubmed:year	2001
pubmed:articleTitle	Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial.
pubmed:affiliation	Department of Medicine, University of Sydney, Nepean Hospital, Penrith NSW, Australia.

More...